UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

Long-Term Efficacy of a Hepatitis E Vaccine

The New England journal of medicine, 2015-03, Vol.372 (10), p.914-922

2015

Link zum Volltext

Verfügbarkeit prüfen

Virus-mimetic nanovesicles as a versatile antigen-delivery system

Proceedings of the National Academy of Sciences - PNAS, 2015-11, Vol.112 (45), p.E6129-E6138

2015

Link zum Volltext

Verfügbarkeit prüfen

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

PloS one, 2015-06, Vol.10 (6), p.e0130209-e0130209

2015

Link zum Volltext

Verfügbarkeit prüfen

Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy

Journal of hepatology, 2021-06, Vol.74 (6), p.1315-1324

2021

Link zum Volltext

Verfügbarkeit prüfen

EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo

Clinical & translational immunology, 2020-05, Vol.9 (5), p.e01135-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

Nature communications, 2020-08, Vol.11 (1), p.3971-3971, Article 3971

2020

Link zum Volltext

Verfügbarkeit prüfen

Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg‐Positive Children With a Normal Alanine Aminotransferase Level

Hepatology (Baltimore, Md.), 2019-12, Vol.70 (6), p.1903-1912

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

BMC cancer, 2022-03, Vol.22 (1), p.287-287, Article 287

2022

Link zum Volltext

Verfügbarkeit prüfen

The development of a recombinant hepatitis E vaccine HEV 239

Human vaccines & immunotherapeutics, 2015-04, Vol.11 (4), p.908-914

2015

Link zum Volltext

Verfügbarkeit prüfen

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

Nature communications, 2017-11, Vol.8 (1), p.1877-7, Article 1877

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near‐normal alanine aminotransferase levels

Hepatology research, 2018-02, Vol.48 (3), p.E133-E145

2018

Link zum Volltext

Verfügbarkeit prüfen

An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients

Transfusion (Philadelphia, Pa.), 2013-10, Vol.53 (10pt2), p.2505-2511

2013

Link zum Volltext

Verfügbarkeit prüfen

Recent progress in antibody-based therapeutics for triple-negative breast cancer

Expert opinion on drug delivery, 2022-07, Vol.19 (7), p.815-832

2022

Link zum Volltext

Verfügbarkeit prüfen

A valuable antigen detection method for diagnosis of acute hepatitis E

Journal of clinical microbiology, 2015-03, Vol.53 (3), p.782-788

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety of the hepatitis E vaccine for pregnant women: A preliminary analysis

Hepatology (Baltimore, Md.), 2012-06, Vol.55 (6), p.2038-2038

2012

Link zum Volltext

Verfügbarkeit prüfen

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

Frontiers in pharmacology, 2021-02, Vol.11, p.609592-609592

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity

Reviews in medical virology, 2012-09, Vol.22 (5), p.339-349

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women

Science China. Life sciences, 2020-04, Vol.63 (4), p.582-591

2020

Link zum Volltext

Verfügbarkeit prüfen

Structure and function analysis of the C. elegans aminophospholipid translocase TAT-1

Journal of cell science, 2019-02, Vol.132 (5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis E vaccine development: A 14 year odyssey

Human vaccines & immunotherapeutics, 2012-06, Vol.8 (6), p.823-827

2012

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Hepatitis E Virus in Chinese Blood Donors

Journal of Clinical Microbiology, 2010-01, Vol.48 (1), p.317-318

2010

Link zum Volltext

Verfügbarkeit prüfen

A lysine-rich motif in the phosphatidylserine receptor PSR-1 mediates recognition and removal of apoptotic cells

Nature communications, 2015-01, Vol.6 (1), p.5717-5717, Article 5717

2015

Link zum Volltext

Verfügbarkeit prüfen

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy

Journal of gastroenterology, 2013-02, Vol.48 (2), p.159-168

2013

Link zum Volltext

Verfügbarkeit prüfen

Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset

The European respiratory journal, 2020-08

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 155

Suche als RSS-Feed

Aktive Filter

ThemaInfectious Diseases

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(154)
Tagungsberichte
(1)

Sprache

Englisch
(123)
Chinesisch
(35)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Humans
(87)
Life Sciences & Biomedicine
(80)
Female
(30)
Animals
(28)
Hepatitis E Virus - Immunology
(26)
Adult
(25)
Male
(25)
Middle Aged
(20)
Hepatitis E Virus
(18)
Gastroenterology & Hepatology
(17)
Hepatitis
(17)
Hepatitis E Virus - Genetics
(16)
Aged
(15)
Vaccines
(15)
Virology
(15)
Young Adult
(15)
Biotechnology & Applied Microbiology
(14)
Immunogenicity
(14)
Adolescent
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long-Term Efficacy of a Hepatitis E Vaccine

Virus-mimetic nanovesicles as a versatile antigen-delivery system

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy

EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo

Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans

Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg‐Positive Children With a Normal Alanine Aminotransferase Level

Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

The development of a recombinant hepatitis E vaccine HEV 239

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near‐normal alanine aminotransferase levels

An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients

Recent progress in antibody-based therapeutics for triple-negative breast cancer

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice

A valuable antigen detection method for diagnosis of acute hepatitis E

Safety of the hepatitis E vaccine for pregnant women: A preliminary analysis

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity

Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women

Structure and function analysis of the C. elegans aminophospholipid translocase TAT-1

Hepatitis E vaccine development: A 14 year odyssey

Prevalence of Hepatitis E Virus in Chinese Blood Donors

A lysine-rich motif in the phosphatidylserine receptor PSR-1 mediates recognition and removal of apoptotic cells

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy

Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset

Aktive Filter

Suchergebnisse filtern